ecr – Übersetzung – Keybot-Wörterbuch

Spacer TTN Translation Network TTN TTN Login Français English Spacer Help
Ausgangssprachen Zielsprachen
Keybot 9 Ergebnisse  www.bikebiz.com
  La prophylaxie pré-expo...  
Des données probantes laissent croire que la PrEP intermittente, ou à la demande, réduit le risque de transmission du VIH parmi les HARSAH. Un ECR particulier du nom d’IPERGAY a évalué l’usage de la PrEP à la demande par des HARSAH.
Evidence suggests that intermittent, or on-demand, PrEP reduces the risk of HIV transmission among MSM. One RCT, known as IPERGAY, evaluated the use of on-demand PrEP among MSM. No studies have been conducted in other populations.
  La prophylaxie pré-expo...  
Au début, certains s’inquiétaient de la possibilité que la PrEP soit inefficace chez les femmes parce que deux ECR n’avaient trouvé aucune réduction du risque de VIH chez des femmes hétérosexuelles qui prenaient la PrEP orale quotidienne.
There is some evidence showing that the drugs in PrEP take longer to reach maximum levels in vaginal tissues compared to rectal tissues, and that drug levels are lower in vaginal tissues. This suggests that daily dosing of oral PrEP may be more important for women having vaginal sex to maintain sufficient drug levels to help prevent HIV infection.
  La prophylaxie pré-expo...  
Les données d’ECR portent à croire que la PrEP orale est aussi efficace chez les femmes que chez les hommes lorsqu’elle est utilisée régulièrement et correctement, mais l’observance thérapeutique pourrait être un facteur plus important chez les femmes.
There were initial concerns that PrEP may not work for women because two RCTs did not find a reduced risk of HIV in heterosexual women taking daily oral PrEP. However, adherence was very low in these studies with only a small proportion of women taking PrEP daily.
  La prophylaxie pré-expo...  
Sans tenir compte de l’observance, la réduction globale du risque assurée par un régime quotidien de PrEP orale lors des ECR allait de zéro à 86 %. Toutes les études ont évalué le risque de transmission sexuelle sauf une, laquelle a révélé une réduction globale du risque de 49 % chez des personnes qui s’injectaient des drogues.
Before taking adherence into account, the overall risk reduction provided by a daily oral PrEP regimen in RCTs ranged from zero to 86%. All of these studies evaluated the sexual transmission risk except for one, which found a 49% overall risk reduction in people who inject drugs. The wide range of protection observed in these trials has been explained by varying levels of adherence to daily pill taking.
  La prophylaxie pré-expo...  
Les données probantes d’essais randomisés et contrôlés (ECR) indiquent que la PrEP orale quotidienne est une stratégie hautement efficace pour réduire le risque de transmission sexuelle du VIH si elle est utilisée régulièrement et correctement dans le cadre d’un programme de prévention complet par les hommes ayant des relations sexuelles avec d’autres hommes (HARSAH) et les hommes et femmes hétérosexuels.
There is evidence from randomized clinical controlled trials (RCTs) that daily oral PrEP is a highly effective strategy to reduce the risk of the sexual transmission of HIV if taken consistently and correctly as part of a comprehensive prevention package in gay men and other men who have sex with men (MSM) and in heterosexual men and women. In addition, limited evidence from one RCT found that daily oral PrEP (with tenofovir alone), when used consistently and correctly, is effective at reducing the risk of HIV transmission among people who inject drugs.
  La prophylaxie pré-expo...  
Les données probantes d’essais randomisés et contrôlés (ECR) indiquent que la PrEP orale quotidienne est une stratégie hautement efficace pour réduire le risque de transmission sexuelle du VIH si elle est utilisée régulièrement et correctement dans le cadre d’un programme de prévention complet par les hommes ayant des relations sexuelles avec d’autres hommes (HARSAH) et les hommes et femmes hétérosexuels.
There is evidence from randomized clinical controlled trials (RCTs) that daily oral PrEP is a highly effective strategy to reduce the risk of the sexual transmission of HIV if taken consistently and correctly as part of a comprehensive prevention package in gay men and other men who have sex with men (MSM) and in heterosexual men and women. In addition, limited evidence from one RCT found that daily oral PrEP (with tenofovir alone), when used consistently and correctly, is effective at reducing the risk of HIV transmission among people who inject drugs.
  La prophylaxie pré-expo...  
Lors d’une étude ouverte en particulier, on a constaté que le risque de VIH a diminué globalement de 86 % parmi les HARSAH qui prenaient une PrEP orale quotidienne, comparativement aux HARSAH ne recevant pas de PrEP. Lors des études ouvertes, le taux d’observance de la prise quotidienne des pilules a été plus élevé que lors des ECR.
The daily use of oral PrEP has also been evaluated in “open-label” studies, predominantly among MSM. In these types of studies, no placebo is used and all participants know they are taking PrEP and that it is effective at preventing HIV transmission. These studies support the finding that oral PrEP is highly effective at reducing HIV transmission when taken consistently and correctly. One open-label study found that the risk for HIV was reduced by 86% overall among MSM who were taking daily oral PrEP compared to those who were not. In open-label studies, adherence to daily pill taking was higher than in RCTs.
  La prophylaxie pré-expo...  
Lors de la phase ECR d’IPERGAY, on a constaté une réduction du risque d’infection par le VIH de 86 % chez les HARSAH du groupe qui prenait la PrEP à la demande, comparativement aux hommes du groupe placebo (deux participants du volet PrEP ont contracté le VIH).
In the IPERGAY trial, MSM were to take two pills two to 24 hours before first sexual activity, followed by one pill taken daily until 48 hours after the last sexual activity. The RCT phase of IPERGAY found an 86% reduced risk of HIV infection among MSM in the on-demand PrEP group compared to those in a placebo group (two participants in the PrEP arm became infected). Men in the RCT phase of this study had sex frequently and – as a result – took their pills on a regular basis (four pills a week on average). IPERGAY continued as an open-label extension with all participants offered on-demand PrEP. Results from the open-label phase showed that one more HIV transmission occurred in 362 participants, over 515 person-years of follow-up (equivalent to following 515 people for one year). None of the three participants who became infected over the entire course of the study had PrEP detected in their blood, which means they were likely not adherent. On-demand PrEP has only been evaluated in MSM and is not recommended for people who have vaginal sex or people who inject drugs.
  La prophylaxie pré-expo...  
Lors de la phase ECR d’IPERGAY, on a constaté une réduction du risque d’infection par le VIH de 86 % chez les HARSAH du groupe qui prenait la PrEP à la demande, comparativement aux hommes du groupe placebo (deux participants du volet PrEP ont contracté le VIH).
In the IPERGAY trial, MSM were to take two pills two to 24 hours before first sexual activity, followed by one pill taken daily until 48 hours after the last sexual activity. The RCT phase of IPERGAY found an 86% reduced risk of HIV infection among MSM in the on-demand PrEP group compared to those in a placebo group (two participants in the PrEP arm became infected). Men in the RCT phase of this study had sex frequently and – as a result – took their pills on a regular basis (four pills a week on average). IPERGAY continued as an open-label extension with all participants offered on-demand PrEP. Results from the open-label phase showed that one more HIV transmission occurred in 362 participants, over 515 person-years of follow-up (equivalent to following 515 people for one year). None of the three participants who became infected over the entire course of the study had PrEP detected in their blood, which means they were likely not adherent. On-demand PrEP has only been evaluated in MSM and is not recommended for people who have vaginal sex or people who inject drugs.